Alembic Pharma

{
  "main_header": {
    "sid": 807696,
    "name": "Alembic Pharma",
    "stock_name": "Alembic Pharma",
    "full_name": "Alembic Pharmaceuticals Ltd.",
    "name_url": "stocks-analysis/alembic-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "785.40",
    "chg": 8.05,
    "chgp": "1.04%",
    "dir": 1,
    "prev_price": "777.35",
    "mcapval": "15,616.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 533573,
    "symbol": "APLLTD",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE901L01018",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": "4.23 lacs",
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alembic-pharma-807696-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Alembic Pharmaceuticals Ltd. is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alembic-pharmaceuticals-ltd-is-rated-sell-3969988",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AlembicPharmace_mojoScore_3969988.png",
        "date": "2026-04-30 10:10:38",
        "description": "Alembic Pharmaceuticals Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Alembic Pharmaceuticals Ltd. is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alembic-pharmaceuticals-ltd-is-rated-sell-3952947",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AlembicPharmace_mojoScore_3952947.png",
        "date": "2026-04-19 10:10:25",
        "description": "Alembic Pharmaceuticals Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Alembic Pharmaceuticals Ltd. Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alembic-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-market-signals-3948304",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AlembicPharmace_technicaldot_3948304.png",
        "date": "2026-04-16 08:05:13",
        "description": "Alembic Pharmaceuticals Ltd. has experienced a nuanced shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook as of late November 2025. Despite a modest day gain of 1.51%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum tools. This analysis delves into the recent technical parameter changes, price momentum, and comparative market performance to provide investors with a comprehensive view of the stock’s current positioning."
      },
      {
        "title": "Alembic Pharmaceuticals Ltd. Surges 7.92% to Day's High of Rs 730.05 — Outperforms Sector by 4.03 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alembic-pharmaceuticals-ltd-hits-intraday-high-with-792-surge-on-8-april-2026-3938004",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AlembicPharmace_priceRelatedfactors_3938004.png",
        "date": "2026-04-08 15:31:02",
        "description": "The Sensex climbed 4.03% on 8 Apr 2026, yet Alembic Pharmaceuticals Ltd. outpaced the broader market with a robust 7.92% gain, reaching an intraday high of Rs 730.05. This 4.03-percentage-point outperformance signals a distinctly stock-specific rally rather than a mere market tailwind."
      },
      {
        "title": "Alembic Pharmaceuticals Ltd. is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alembic-pharmaceuticals-ltd-is-rated-sell-3937518",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AlembicPharmace_mojoScore_3937518.png",
        "date": "2026-04-08 10:10:03",
        "description": "Alembic Pharmaceuticals Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Alembic Pharmaceuticals Ltd. is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alembic-pharmaceuticals-ltd-is-rated-sell-3921497",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlembicPharmace_mojoScore_3921497.png",
        "date": "2026-03-28 10:10:15",
        "description": "Alembic Pharmaceuticals Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Alembic Pharmaceuticals Ltd. Falls to 52-Week Low of Rs 645.1 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alembic-pharmaceuticals-ltd-stock-hits-52-week-low-amid-sector-and-market-downturn-3908012",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlembicPharmace_priceRelatedfactors_3908012.png",
        "date": "2026-03-23 13:21:25",
        "description": "A sharp decline of 4.72% today dragged Alembic Pharmaceuticals Ltd. to a fresh 52-week low of Rs 645.1, extending a downward trend that has seen the stock lose nearly 32% over the past year. This underperformance stands in stark contrast to the broader market, with the Sensex down just 5.56% over the same period."
      },
      {
        "title": "Alembic Pharmaceuticals Ltd. Stock Hits 52-Week Low at Rs.659.55",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alembic-pharmaceuticals-ltd-stock-hits-52-week-low-at-rs65955-3899977",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlembicPharmace_priceRelatedfactors_3899977.png",
        "date": "2026-03-19 09:58:43",
        "description": "Alembic Pharmaceuticals Ltd. has reached a new 52-week low, with its stock price falling to Rs.659.55 today. This marks a significant decline amid broader market fluctuations and ongoing sector pressures, reflecting a challenging period for the company within the Pharmaceuticals & Biotechnology industry."
      },
      {
        "title": "Alembic Pharmaceuticals Ltd. Stock Falls to 52-Week Low of Rs.665.1",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alembic-pharmaceuticals-ltd-stock-falls-to-52-week-low-of-rs6651-3896970",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AlembicPharmace_priceRelatedfactors_3896970.png",
        "date": "2026-03-17 15:46:16",
        "description": "Alembic Pharmaceuticals Ltd. has reached a new 52-week low of Rs.665.1 today, marking a significant decline in its stock price amid a series of consecutive falls and underperformance relative to its sector and benchmark indices."
      }
    ],
    "total": 5279,
    "sid": "807696",
    "stock_news_url": "https://www.marketsmojo.com/news/alembic-pharmaceuticals-807696"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "05-May-2026",
      "details": "Please find enclosed.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Under Reg 30 Of SEBI (LODR) Regulations 2015",
      "datetime": "04-May-2026",
      "details": "Please find attached",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "04-May-2026",
      "details": "Resignation of Senior Management Personnel.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "15 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alembic Pharmaceuticals Ltd. has declared <strong>550%</strong> dividend, ex-date: 29 Jul 25",
          "dt": "2025-07-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Alembic Pharmaceuticals Ltd. is Rated Sell

2026-04-30 10:10:38

Alembic Pharmaceuticals Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Alembic Pharmaceuticals Ltd. is Rated Sell

2026-04-19 10:10:25

Alembic Pharmaceuticals Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Alembic Pharmaceuticals Ltd. Technical Momentum Shifts Amid Mixed Market Signals

2026-04-16 08:05:13

Alembic Pharmaceuticals Ltd. has experienced a nuanced shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook as of late November 2025. Despite a modest day gain of 1.51%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum tools. This analysis delves into the recent technical parameter changes, price momentum, and comparative market performance to provide investors with a comprehensive view of the stock’s current positioning.

Read full news article

Alembic Pharmaceuticals Ltd. Surges 7.92% to Day's High of Rs 730.05 — Outperforms Sector by 4.03 Percentage Points

2026-04-08 15:31:02

The Sensex climbed 4.03% on 8 Apr 2026, yet Alembic Pharmaceuticals Ltd. outpaced the broader market with a robust 7.92% gain, reaching an intraday high of Rs 730.05. This 4.03-percentage-point outperformance signals a distinctly stock-specific rally rather than a mere market tailwind.

Read full news article

Alembic Pharmaceuticals Ltd. is Rated Sell

2026-04-08 10:10:03

Alembic Pharmaceuticals Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Alembic Pharmaceuticals Ltd. is Rated Sell

2026-03-28 10:10:15

Alembic Pharmaceuticals Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Alembic Pharmaceuticals Ltd. Falls to 52-Week Low of Rs 645.1 as Sell-Off Deepens

2026-03-23 13:21:25

A sharp decline of 4.72% today dragged Alembic Pharmaceuticals Ltd. to a fresh 52-week low of Rs 645.1, extending a downward trend that has seen the stock lose nearly 32% over the past year. This underperformance stands in stark contrast to the broader market, with the Sensex down just 5.56% over the same period.

Read full news article

Alembic Pharmaceuticals Ltd. Stock Hits 52-Week Low at Rs.659.55

2026-03-19 09:58:43

Alembic Pharmaceuticals Ltd. has reached a new 52-week low, with its stock price falling to Rs.659.55 today. This marks a significant decline amid broader market fluctuations and ongoing sector pressures, reflecting a challenging period for the company within the Pharmaceuticals & Biotechnology industry.

Read full news article

Alembic Pharmaceuticals Ltd. Stock Falls to 52-Week Low of Rs.665.1

2026-03-17 15:46:16

Alembic Pharmaceuticals Ltd. has reached a new 52-week low of Rs.665.1 today, marking a significant decline in its stock price amid a series of consecutive falls and underperformance relative to its sector and benchmark indices.

Read full news article

View All News